Treatment with the antibiotic azithromycin did not prevent the development of lung damage in infants with cystic fibrosis…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
When an initial antibiotic failed to improve lung function with a pulmonary exacerbation, switching antibiotics did not lead to greater…
Treatment with Kalydeco (ivacaftor) led to improved lung function and weight gain as well as fewer respiratory infections and…
Researchers at Stanford University have been awarded £210,000 (about $265,000) to study preventing hearing loss caused by a class of…
People from ethnic minority backgrounds were significantly less likely to be eligible for the cystic fibrosis therapy Kaftrio…
Several potential biomarkers of nontuberculosis mycobacteria (NTM)-associated lung disease were identified in the breath of people with cystic fibrosis…
The presence of lung disease was low among infants with cystic fibrosis (CF) and was not associated with respiratory…
A noninvasive imaging technique called elastography can detect the degree of liver fibrosis, or scarring, in children with cystic…
The Cystic Fibrosis Foundation (CFF) has awarded $1.6 million to support research focused on identifying biomarkers of chronic lung…
A noninvasive measurement of lung function called lung clearance index (LCI) was associated with the degree of lung damage over…